1mon
GlobalData on MSNSanofi moves closer to selling controlling stake in $17bn-valued OpellaSanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share ...
Bpifrance is expected to participate as a minority shareholder with a c.2% stake in Opella, with Sanofi remaining a significant shareholder. The terms of the transaction remain unchanged from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results